1) ACA microcapsule immobilized enzyme
ACA微胶囊固定酶
3) ACA microcapsule
ACA微胶囊
1.
The exudation and separation of aloe polysaccharides and anthraquinones were studied in the process of ACA microcapsule formation and 24h(equilibrium) dialysis.
应用自行研制的ACA(Alginate-Chitosan-Alginate)微胶囊技术体系,考察了芦荟液ACA微胶囊成囊过程及微胶囊24h平衡透析过程中芦荟多糖、芦荟蒽醌类化合物渗透分离情况。
2.
Alginate/chitosan microcapsules (ACA microcapsules) have been proven to be potential drug delivery carrier for biopharmaceuticals, due to material characteristics (biocompatibility, biodegradability and biadhesiveness) and mild reaction characteristics.
以海藻酸钙凝胶珠外覆壳聚糖膜形成的微胶囊(ACA微胶囊)因其良好的材料特性(生物相容性、可降解性和粘附性)及温和的反应特性而成为最具潜力的生化药物释放载体。
6) Immobilized GL-7-ACA Acylase
固定化GL-7-ACA酰化酶
1.
Preparing D-7-ACA with tri-enzyme method(Immobilized D-amino acid oxidase,Immobilized GL-7-ACA Acylase,Immobilized deacetyl esterase) is an original,sustainable and brand new technology in promoting the development of green pharmaceutical industry in our country.
三酶(D-氨基酸氧化酶、固定化GL-7-ACA酰化酶和固定化去乙酰基酯酶)法制备D-7-ACA工艺,属国内首创的新技术、新工艺,有利于我国绿色制药工业的发展,是一种可持续的工艺路线。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条